Related references
Note: Only part of the references are listed.Sex-mediated elevation of the specialized pro-resolving lipid mediator levels in a Sjogren's syndrome mouse model
Kaustubh Parashar et al.
FASEB JOURNAL (2020)
Inflammation and its resolution in atherosclerosis: mediators and therapeutic opportunities
Magnus Back et al.
NATURE REVIEWS CARDIOLOGY (2019)
An omega-3 fatty acid plasma index ≥4% prevents progression of coronary artery plaque in patients with coronary artery disease on statin treatment
Abdulhamied Alfaddagh et al.
ATHEROSCLEROSIS (2019)
The G-protein coupled receptor ChemR23 determines smooth muscle cell phenotypic switching to enhance high phosphate-induced vascular calcification
Miguel Carracedo et al.
CARDIOVASCULAR RESEARCH (2019)
Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia
Deepak L. Bhatt et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
ERV1/ChemR23 Signaling Protects Against Atherosclerosis by Modifying Oxidized Low-Density Lipoprotein Uptake and Phagocytosis in Macrophages
Andres Laguna-Fernandez et al.
CIRCULATION (2018)
Resolvin E1 attenuates injury-induced vascular neointimal formation by inhibition of inflammatory responses and vascular smooth muscle cell migration
Guizhu Liu et al.
FASEB JOURNAL (2018)
Resolvins in inflammation: emergence of the pro-resolving superfamily of mediators
Charles N. Serhan et al.
JOURNAL OF CLINICAL INVESTIGATION (2018)
Pro-resolving lipid mediators in vascular disease
Michael S. Conte et al.
JOURNAL OF CLINICAL INVESTIGATION (2018)
Opposing Effects on Vascular Smooth Muscle Cell Proliferation and Macrophage-induced Inflammation Reveal a Protective Role for the Proresolving Lipid Mediator Receptor ChemR23 in Intimal Hyperplasia
Gonzalo Artiach et al.
FRONTIERS IN PHARMACOLOGY (2018)
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
P. M. Ridker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Effect of Eicosapentaenoic and Docosahexaenoic Acids Added to Statin Therapy on Coronary Artery Plaque in Patients With Coronary Artery Disease: A Randomized Clinical Trial
Abdulhamied Alfaddagh et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2017)
Resolvin E1 attenuates atherosclerosis in absence of cholesterol-lowering effects and on top of atorvastatin
Kanita Salic et al.
ATHEROSCLEROSIS (2016)
Resolving Lipid Mediators Maresin 1 and Resolvin D2 Prevent Atheroprogression in Mice
Joana R. Viola et al.
CIRCULATION RESEARCH (2016)
Specialized proresolving lipid mediators in patients with coronary artery disease and their potential for clot remodeling
Tarec K. Elajami et al.
FASEB JOURNAL (2016)
An imbalance between specialized pro-resolving lipid mediators and pro-inflammatory leukotrienes promotes instability of atherosclerotic plaques
Gabrielle Fredman et al.
NATURE COMMUNICATIONS (2016)
Effect of Targeting Inflammation With Salsalate The TINSAL-CVD Randomized Clinical Trial on Progression of Coronary Plaque in Overweight and Obese Patients Using Statins
Thomas H. Hauser et al.
JAMA CARDIOLOGY (2016)
Resolvin E1 (RvE1) Attenuates Atherosclerotic Plaque Formation in Diet and Inflammation-Induced Atherogenesis
Hatice Hasturk et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2015)
Identification and signature profiles for pro-resolving and inflammatory lipid mediators in human tissue
Romain A. Colas et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2014)
Inflammation and its Resolution as Determinants of Acute Coronary Syndromes
Peter Libby et al.
CIRCULATION RESEARCH (2014)
Pro-resolving lipid mediators are leads for resolution physiology
Charles N. Serhan
NATURE (2014)
The Pro-Resolving Lipid Mediator Maresin 1 (MaR1) Attenuates Inflammatory Signaling Pathways in Vascular Smooth Muscle and Endothelial Cells
Anuran Chatterjee et al.
PLOS ONE (2014)
Comparison of coronary plaque subtypes in male and female patients using 320-row MDCTA
Faisal Khosa et al.
ATHEROSCLEROSIS (2013)
Anti-Inflammatory Therapy in Chronic Disease: Challenges and Opportunities
Ira Tabas et al.
SCIENCE (2013)
Role of Basic Science in the Development of New Medicines: Examples from the Eicosanoid Field
Bengt Samuelsson
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Resolvin E2 Formation and Impact in Inflammation Resolution
Sungwhan F. Oh et al.
JOURNAL OF IMMUNOLOGY (2012)
Infection regulates pro-resolving mediators that lower antibiotic requirements
Nan Chiang et al.
NATURE (2012)
Resolvin E1 promotes phagocytosis-induced neutrophil apoptosis and accelerates resolution of pulmonary inflammation
Driss El Kebir et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Specialized proresolving mediator targets for RvE1 and RvD1 in peripheral blood and mechanisms of resolution
Gabrielle Fredman et al.
BIOCHEMICAL JOURNAL (2011)
Lipoxygenase and Leukotriene Pathways: Biochemistry, Biology, and Roles in Disease
Jesper Z. Haeggstrom et al.
CHEMICAL REVIEWS (2011)
Pro-resolving actions and stereoselective biosynthesis of 18S E-series resolvins in human leukocytes and murine inflammation
Sungwhan F. Oh et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
The immune system in atherosclerosis
Goran K. Hansson et al.
NATURE IMMUNOLOGY (2011)
Clinical Predictors of Plaque Progression Despite Very Low Levels of Low-Density Lipoprotein Cholesterol
Ozgur Bayturan et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2010)
Intravascular Ultrasound-Derived Measures of Coronary Atherosclerotic Plaque Burden and Clinical Outcome
Stephen J. Nicholls et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2010)
Macrophage death and defective inflammation resolution in atherosclerosis
Ira Tabas
NATURE REVIEWS IMMUNOLOGY (2010)
Resolvin E1, an EPA-derived mediator in whole blood, selectively counterregulates leukocytes and platelets
Maria Dona et al.
BLOOD (2008)
Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators
Charles N. Serhan et al.
NATURE REVIEWS IMMUNOLOGY (2008)
Stereochemical assignment, antiinflammatory properties, and receptor for the omega-3 lipid mediator resolvin E1
M Arita et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Lipid mediator class switching during acute inflammation: signals in resolution
BD Levy et al.
NATURE IMMUNOLOGY (2001)
Novel functional sets of lipid-derived mediators with antiinflammatory actions generated from omega-3 fatty acids via cyclooxygenase 2-nonsteroidal antiinflammatory drugs and transcellular processing
CN Serhan et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2000)
Share Paper
